BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 183 participants.

Also called NCT04891380

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 183 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04891380
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Norway (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04891380. Non-randomized; no masking; primary purpose treatment. Start 2021-05-18 (actual); primary completion 2024-01-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study
Condition
Cardiac Arrest, Out-Of-Hospital
Condition
Hypotension and Shock
Intervention (Device)
LUCAS 2 Active Decompression 2
Intervention (Other)
Hypotension
Intervention (Other)
Intensive care transport
Lead sponsor
Oslo University Hospital (class: other)
Collaborator
Norwegian Telemedicine (class: not stated)
Collaborator
Kopera Norway (class: not stated)
Collaborator
Edwards Medical (class: not stated)
Collaborator
Stryker Medical (class: industry)
Collaborator
University of Bilbao (class: not stated)
Collaborator
University of Stavanger (class: other)

Record details

Record id
cardio:ct-nct04891380
Content hash
f2d241449f78965b639b81a5813653d898dbc81841d40c5f0c77e45601f2be91